Hailan Wu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

The efflux pump QacA mediates the transition to vancomycin heteroresistance in sequence type 5 methicillin-resistant Staphylococcus aureus via membrane lipid reprogramming.

The efflux pump QacA mediates the transition to vancomycin heteroresistance in sequence type 5 methicillin-resistant Staphylococcus aureus via membrane lipid reprogramming.

Journal: Emerging microbes & infections

Published: July 27, 2026

Evaluation of the clinical efficacy, safety, and permeability in pulmonary epithelial lining fluid of contezolid, a novel oxazolidinone drug, in adult patients with pneumonia.

Evaluation of the clinical efficacy, safety, and permeability in pulmonary epithelial lining fluid of contezolid, a novel oxazolidinone drug, in adult patients with pneumonia.

Journal: Antimicrobial agents and chemotherapy

Published: March 04, 2026

Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections.

Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections.

Journal: International journal of antimicrobial agents

Published: February 19, 2026

qacA is a key factor in heteroresistance to vancomycin in sequence type 5 methicillin-resistant Staphylococcus aureus isolates from pneumonia patients.

qacA is a key factor in heteroresistance to vancomycin in sequence type 5 methicillin-resistant Staphylococcus aureus isolates from pneumonia patients.

Journal: Microbiology spectrum

Published: February 02, 2026

Limited association between serum vancomycin pharmacokinetic/ pharmacodynamic indices and clinical outcomes in gram-positive complicated urinary tract infections.

Limited association between serum vancomycin pharmacokinetic/ pharmacodynamic indices and clinical outcomes in gram-positive complicated urinary tract infections.

Journal: Frontiers in pharmacology

Published: December 20, 2025

Comparative efficacy and safety of high-dose rifamycin regimens for tuberculosis treatment: a Bayesian network meta-analysis.

Comparative efficacy and safety of high-dose rifamycin regimens for tuberculosis treatment: a Bayesian network meta-analysis.

Journal: BMJ open

Published: October 05, 2025

Penetration of Contezolid into bone tissues and body fluids in patients undergoing artificial hip or knee replacement surgery: A prospective cohort study.

Penetration of Contezolid into bone tissues and body fluids in patients undergoing artificial hip or knee replacement surgery: A prospective cohort study.

Journal: Journal of global antimicrobial resistance

Published: March 04, 2025

Model-informed precision dosing of vancomycin in Chinese adult patients receiving renal replacement therapy: Systematic evaluation of published pharmacokinetic models and dosing regimen simulations.

Model-informed precision dosing of vancomycin in Chinese adult patients receiving renal replacement therapy: Systematic evaluation of published pharmacokinetic models and dosing regimen simulations.

Journal: International journal of antimicrobial agents

Published: January 07, 2025

Aerosolized delivery resulting in high polymyxin B concentration levels in epithelial lining fluid ensures efficacy in ventilator-associated pneumonia.

Aerosolized delivery resulting in high polymyxin B concentration levels in epithelial lining fluid ensures efficacy in ventilator-associated pneumonia.

Journal: JAC-antimicrobial resistance

Published: September 16, 2024

Model-guided development of pharmacokinetic/pharmacodynamic cut-offs and evaluation of sitafloxacin dosing regimens against target pathogens.

Model-guided development of pharmacokinetic/pharmacodynamic cut-offs and evaluation of sitafloxacin dosing regimens against target pathogens.

Journal: Frontiers in pharmacology

Published: August 05, 2024

Age-Related Differences in Vancomycin-Associated Nephrotoxicity and Efficacy in Methicillin-Resistant Staphylococcus aureus Infection: A Comparative Study between Elderly and Adult Patients.

Age-Related Differences in Vancomycin-Associated Nephrotoxicity and Efficacy in Methicillin-Resistant Staphylococcus aureus Infection: A Comparative Study between Elderly and Adult Patients.

Journal: Antibiotics (Basel, Switzerland)

Published: February 20, 2024

A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects.

A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects.

Journal: International journal of antimicrobial agents

Published: July 09, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026